OncoLink at ASTRO 2011

Coverage of the 2011 Annual Meeting of the American Society for Therapeutic Radiology And Oncology, ASTRO, held in Miami, FL.

A Phase III Randomized Trial of Intermittent vs. Continuous Androgen Suppression for PSA Progression after Radical Therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013) Accord12/0405-prodige 2 Phase III Trial Neoadjuvant Treatment In Rectal Cancer. Results After 3 Years Of Follow-up Cardiovascular Mortality following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08 Comparative Long-term Morbidity of Intensity Modulated vs Conformal Radiation Therapy (RT) for Prostate Cancer: A SEER-Medicare Analysis Comparison Of Intensity Modulated Proton Therapy (IMPT) To Passively Scattered Proton Therapy (PSPT) In The Treatment of Prostate Cancer Electronic Web-Based Technology Significantly Improves Quality of Life (QOL) Data Collection: Analysis of RTOG 0828 FDG Uptake Predicts Recurrence and Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer treated with 74 Gy (RBE) Proton Therapy and Chemotherapy Five Year Results of a Randomized External Beam Radiotherapy Hypofractionation Trial for Prostate Cancer High-dose Proton-beam Based Radiation Therapy with or without Surgery in the Management of Primary and Recurrent Spine Chordomas: A Retrospective Review of Outcomes and Clinicopathologic Prognostic Factors Is Androgen Deprivation Therapy Necessary in Intermediate Risk Prostate Cancer Patients Treated in the Dose escalation Era? Long Term Follow-up After Charged Particle Therapy for Chordomas and Chondrosarcomas of the Head and Neck: the Lawrence Berkeley National Laboratory (LBNL) / University of California San Francisco (UCSF) Experience Long Term Outcomes Comparing Three-Dimensional Conformal Radiation Therapy to Intensity Modulated Radiation Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancer: The MD Anderson Experience Long-term Cause-specific Mortality Of Adolescent And Young Adult (AYA) Survivors Of Bone And Soft Tissue Sarcoma (STS): A Population-based Study Long-term Morbidity of Intensity Modulated vs Conformal Radiation Therapy (RT) for Prostate Cancer: A SEER-Medicare Analysis Long-term Update of U.S. GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Concurrent Chemoradiation with 5FU-Mitomycin Yields Better Disease-Free and Overall Survival than 5FU-Cisplatin Meta-analysis of the Impact of Androgen Deprivation Therapy on Cardiovascular Death in Patients with Prostate Cancer Multi-Institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated with Patient Reported Outcomes Music Relaxation Video and Pain Control: A Randomized Controlled Trial for Women Receiving Intracavitary Brachytherapy for Gynecological Cancer Preliminary Analysis of 3DCRT vs IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Toxicity Report Prospective Randomized Trial Comparing External Beam Radiotherapy versus Watchful Waiting in Early Prostate Cancer (T1b-T2, pN0, Grade 1-2, M0) Proton Beam Therapy for Patients with Malignancies of The Nasal Cavity, Para-nasal Sinuses, and/or Involving the Skull Base: The Analysis of Late Toxicity Randomized Phase III Comparison of Standard Dose (60Gy) Versus High-Dose (74Gy) Conformal Chemoradiotherapy +/- Cetuximab for Stage IIIA/B Non-Small Cell Lung Cancer: Preliminary Findings on Radiation Dose in RTOG 0617 Results from a Prospective Trial of Proton Radiotherapy for Medulloblastoma: Clinical Outcomes including Hearing and Neurocognitive Trends in Radiation Oncology Services in the IMRT Era: Evolving Patterns of Usage and Payments in Medicare Patients From 2000-2009